# A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants.

> **NCT07469085** · PHASE1 · RECRUITING · sponsor: **Shanghai Synvida Biotechnology Co.,Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** SV003
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07469085
- **Lead sponsor:** Shanghai Synvida Biotechnology Co.,Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-04
- **Primary completion:** 2026-10-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07469085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07469085, "A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07469085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*